CyberKnife®, a non-invasive radiosurgery technique, is an innovative treatment for pancreatic cancer.
As Consultant Clinical Oncologists Andrew Gaya and Nick Plowman explain in the following articles, CyberKnife® technology is able to target tumours accurately and deliver radiation with sub-millimetre precision, making it possible to give a large radiation dose, lethal to the tumour, with little risk to the surrounding tissues and minimal side effects.
If the prostate cancer is found early enough CyberKnife® can be used in situations where the patient is unfit for surgery or if the tumour is difficulty placed. CyberKnife® treatment normally takes an hour and is given in up to five treatments.
In the following articles, doctors Nick Plowman, Andrew Gaya, and Chris Nutting give expert advice on CyberKnife®.
Contact a doctor about treatment with CyberKnife®.
Information on Prostate Cancer
Approximately 10,000 men die from prostate cancer every year in the UK but this disease does not have to be a death sentence. Tumours of the prostate are very slow growing and sufferers may therefore delay treatment until there is a risk of the cancer spreading.
Traditional treatments have a variety of side effects including loss of libido, sexual dysfunction, change of physical appearance and urinary incontinence amongst others. Pancreatic cancer is very difficult to treat and detect. It causes very few symptoms and is often not diagnosed until it has reached an advanced stage. Treatment options tend to focus on alleviation of symptoms rather than cure.